ArticleMolecular therapy oncolytics2023

Oncolytic virotherapy with chimeric VSV-NDV synergistically supports RIG-I-dependent checkpoint inhibitor immunotherapy.

Janina Marek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.